Меню
Идёт набор NCT06829901

The Effect of Uterine Entry In Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome

Без фазы С лечением Twin to Twin Transfusion

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Fetoscopic Laser Photocoagulation.
Кому может быть актуально
Состояния в реестре: Twin to Twin Transfusion. Базовые параметры: от 18 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

The Effect of Entry Technique on Chorioamniotic Membrane Separation in Fetoscopic Laser Photocoagulation for Twin-To-Twin Transfusion Syndrome

Обзор

The purpose of this study is to evaluate whether the entry technique surgeons use to get inside the uterus to perform fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome has an effect on the rates of chorioamniotic membrane separation.

Подробное описание

Patients who choose to undergo fetoscopic selective laser photocoagulation (SFLP) at Texas Children's Fetal Center will be offered participation in this research study by study investigators. Description of study rationale and design and a focused interview by the study coordinator to afford potential participants a formal opportunity to examine what they have learned about the research study in the course of their evaluation and discuss how they feel about enrolling in the research study. Once the patient is deemed eligible the informed consent process will be reviewed. If patients elect to participate in the study, informed consent will be obtained, and participants will be provided a copy of the signed consent.

After consent has been obtained, participants will be randomized into two groups ("direct entry" and "Seldinger technique").

Procedure: Selective laser photocoagulation (SFLP) is standard of care for the treatment of complicated monochorionic twin pregnancies. Entry into the uterus for SFLP is achieved under ultrasound guidance using one of two accepted methods, direct entry or the Seldinger technique. Intravenous sedation with local anesthesia at the site of insertion has been found to provide sufficient maternal anesthesia for the procedure.

Group I - Direct entry: The surgeon will gain access to the uterus by inserting a sharp trocar through a small incision in the skin. After access has been established, the trocar is removed and a small tube called a cannula is left in place.

Group II - Seldinger technique: The surgeon will gain access to the uterus by inserting needle through a small incision in the skin and run a guide wire through the needle so a thin tube called a cannula can be placed over the wire.

Follow-Up:

Participants will be monitored after the procedure and upon discharge from the hospital they are free to resume care with their primary doctor. Investigators will collect follow-up data on the health of the participant and the babies until the babies turn one month old.

Вмешательства

  • Процедура Fetoscopic Laser Photocoagulation
    Patients who choose to undergo fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome will be offered participation in the study. All participants will undergo selective laser photocoagulation and entry into the uterus will be achieved using one of two accepted methods, either direct entry or the Seldinger technique.

Первичные конечные точки

  • Rate of Immediate Chorioamniotic Membrane Separation (CAS) [Срок оценки: Up to hospital discharge post-procedure (up to 5 days)]
Вторичные конечные точки (8)
  • Rate of Chorioamniotic Membrane Separation (CAS) [Срок оценки: From the post-surgical period (outside the first 24 hours) until delivery, up to 25 weeks]
  • Gestational Age at Delivery [Срок оценки: At delivery]
  • Preterm Birth [Срок оценки: At delivery]
  • Procedure to Delivery Interval [Срок оценки: At delivery]
  • Placental Abruption [Срок оценки: Up to hospital discharge post-procedure (up to 5 days)]
  • Chorioamnionitis [Срок оценки: Up to hospital discharge post-procedure (up to 5 days)]
  • Septostomy [Срок оценки: Up to hospital discharge post-procedure (up to 5 days)]
  • Preterm Premature Rupture of Membranes (PPROM) [Срок оценки: At delivery]

Критерии участия

Критерии включения

  • Patients who are eligible and elect to undergo fetoscopic selective laser photocoagulation for complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome.
  • Patients will be between 16 0/7 weeks and 26 0/7 weeks gestational age.

Критерии исключения

  • Patients who do not elect to undergo fetoscopic laser photocoagulation for the treatment of complicated monochorionic-diamniotic twin pregnancies with twin-to-twin transfusion syndrome.
  • Triplets and higher order multiple gestations.
  • Patients who are less than 16 0/7 weeks or greater than 26 0/7 weeks gestational age.
  • Patients with a short cervix (less than 1.5 cm).
  • Patients with a known subchorionic hemorrhage.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

США · 1 центр
  • Texas Children's Hospital - Pavilion for Women — Houston

Публикации

  • Burnett BA, Munoz JL, Johnson RM, Parobek CM, Delgadillo Chabolla LE, Buskmiller C, Donepudi RV, Sanz Cortes M, Belfort MA, Nassr AA. The effect of uterine entry technique on chorioamniotic membrane separation in fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome: protocol for a randomized controlled trial. BMC Pregnancy Childbirth. 2025 Nov 21;25(1):1253. doi: 10.1186/s12884- PMID 41272584

Идентификаторы

NCT: NCT06829901 · H-56175

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗